Health / Medical Topics |
Brigatinib
Pronunciation
A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has a mutated (changed) form of a gene called anaplastic lymphoma kinase (ALK). It is used in patients whose cancer has gotten worse during treatment with or who cannot take crizotinib (a type of anticancer drug). Brigatinib blocks certain proteins made by the mutated ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Brigatinib is a type of tyrosine kinase inhibitor. Also called Alunbrig. (NCI Dictionary)
YOU MAY ALSO LIKE
The Brief Symptom Inventory 18 (BSI 18) assessment gathers patient-reported data to help measure psychological distress and psychiatric disorders in medical and…
A disorder characterized by delusions, hallucinations, disorganized speech, and/or grossly disorganized behavior that resolve within a month.
A standardized rating scale originally developed by Margaret G. Woerner, Salvatore Mannuzza and John M. Kane in 1988 which is used to…
A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a…
A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a…
A questionnaire used to measure pain.